Biopol Chemicals IPO GMP 2026: Date, Price & Review
Biopol Chemicals IPO 2026: GMP, Date, Price, Review, Financials & Complete Analysis
The biopol chemicals ipo is one of the latest SME public issues attracting attention in February 2026. With strong revenue growth, improving profitability, and a presence in the specialty chemicals segment, the biopol chemicals limited ipo has become a topic of interest among retail and HNI investors.
About Biopol Chemicals Limited
Biopol Chemicals Limited is a specialty chemicals company incorporated in 2023. Despite being relatively new, the company has scaled operations quickly and operates in a B2B business model.
The company manufactures and supplies more than 66 chemical products catering to industries such as:
- Textiles
- Home care
- Agriculture
- Construction
- Water treatment
Key Product Categories
- Silicones – Used in softeners and industrial fluids
- Emulsifiers – Prevent separation in formulations
- Biochemicals & Polyelectrolytes – Used in water treatment and industrial applications
📍 Manufacturing Unit: West Bengal
📍 Registered Office: Gujarat
The company primarily operates in domestic markets while expanding its industrial footprint.
Biopol Chemicals IPO 2026: Key Details
The biopol chemicals limited ipo is a book-built SME issue worth approximately ₹31.26 crore.
It is a 100% fresh issue, meaning there is no Offer for Sale (OFS). All funds raised will be used for business expansion and corporate purposes.
Minimum Investment Required
Retail investors must apply for at least 2 lots (2400 shares).
At the upper price band of ₹108:
👉 2400 × 108 = ₹2,59,200
Since this is an SME IPO, the capital requirement is significantly higher than mainboard IPOs.
Biopol Chemicals IPO GMP (Grey Market Premium)
The biopol chemicals ipo gmp is currently reported as:
- Current GMP: ₹0
- Estimated Listing Price: ₹108
- Expected Listing Gain: 0%
- Market Sentiment: Neutral
A flat biopol chemicals limited ipo gmp indicates that grey market traders are in a wait-and-watch mode.
What Does Flat GMP Indicate?
- Market participants are cautious
- Investors are waiting for subscription data
- SME liquidity risk is being considered
⚠ Remember: GMP is unofficial and speculative. It should not be the sole basis for investment decisions.
Financial Performance of Biopol Chemicals Limited
Before applying for the biopol chemicals ipo, reviewing the company’s financial growth is essential.
Financial Highlights
Growth Analysis
✔ Revenue nearly doubled in one year
✔ Profit growth is consistent
✔ Net worth expanding steadily
✔ Borrowings increasing but manageable
Key Financial Ratios
- ROE: ~38%
- ROCE: ~30%
- Debt/Equity Ratio: 0.57
These ratios indicate efficient capital usage and decent profitability for a young company.
Valuation Analysis
At the upper price band of ₹108 and FY25 EPS of ₹5.47:
👉 Approximate P/E Ratio = ~19.7x
For an SME specialty chemical company with high growth, this valuation appears reasonable but not undervalued.
Investors must weigh valuation against:
- Limited operating history
- SME liquidity risks
- Future scalability
Strengths of Biopol Chemicals Limited
1. Strong Financial Growth
Revenue and PAT have shown consistent upward movement.
2. Diversified Product Portfolio
66+ products reduce dependency on a single segment.
3. Attractive Profitability Ratios
ROE and ROCE are strong for an SME company.
4. Fresh Issue Structure
Funds will go directly into expansion rather than promoter exit.
Risks and Concerns
1. Limited Track Record
The company was incorporated in 2023, which means limited historical performance data.
2. SME Liquidity Risk
SME stocks often have lower trading volumes post listing.
3. Increasing Borrowings
Debt has increased in recent financial periods.
4. Flat GMP Sentiment
Grey market does not indicate strong listing enthusiasm.
IPO Objectives
The proceeds from the biopol chemicals limited ipo will be used for:
- Acquisition of industrial land
- Repayment or prepayment of borrowings
- General corporate purposes
Allotment & Listing Information
- Basis of Allotment: February 11, 2026
- Refund Initiation: February 11, 2026
- Shares Credited to Demat: February 12, 2026
- Listing Date: February 13, 2026
- Listing Platform: NSE Emerge
Should You Apply for Biopol Chemicals IPO?
For Short-Term Investors
Listing gains appear uncertain due to flat GMP. Monitor subscription data carefully.
For Long-Term Investors
If you are comfortable with SME risk and believe in the specialty chemicals growth story, it may be considered with moderate allocation.
For Conservative Investors
You may avoid due to limited track record and SME volatility.
Final Verdict
The biopol chemicals ipo presents a growth-oriented SME opportunity in the specialty chemicals sector. Financial performance is strong for a young company, and profitability ratios are attractive. However, limited operating history and SME liquidity risks must not be ignored.
Investors should analyze:
- Subscription response
- Updated GMP trend
- Risk appetite
- Portfolio allocation strategy
Before making an investment decision.
FAQ’s
1. What is the price band of Biopol Chemicals IPO?
The price band is ₹102 to ₹108 per share.
2. What is the minimum investment in Biopol Chemicals IPO?
Retail investors must invest at least ₹2,59,200 (2 lots).
3. What is the current Biopol Chemicals IPO GMP?
The current GMP is ₹0, indicating neutral grey market sentiment.
4. Is Biopol Chemicals IPO a fresh issue?
Yes, it is a 100% fresh issue.
5. When will Biopol Chemicals IPO list?
The IPO is expected to list on February 13, 2026.
Disclaimer: Investments in the securities market are subject to market risks. Read all IPO-related documents carefully before investing.
